Symptom Distress In Patients Research Articles

Rabeprazole relieves Symptom distress in patients with non-erosive Gastroesophageal reflux disease (GERD)

Rabeprazole relieves Symptom distress in patients with non-erosive Gastroesophageal reflux disease (GERD)

Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study.

Delirium impedes communication and contributes to symptom distress in patients with advanced cancer. There are few prospective data on the reversal of delirium in this population. To evaluate the occurrence, precipitating factors, and reversibility of delirium in patients with advanced cancer. Prospective serial assessment in a consecutive cohort of 113 patients with advanced cancer. Precipitating factors were examined using standardized criteria; 104 patients met eligibility criteria. Acute palliative care unit in a university-affiliated teaching hospital. Delirium occurrence and reversal rates, duration, and patient survival. Strengths of association of various precipitating factors with reversal were expressed as hazard ratios (HRs) in univariate and multivariate analyses. On admission, delirium was diagnosed in 44 patients (42%), and of the remaining 60, delirium developed in 27 (45%). Reversal of delirium occurred in 46 (49%) of 94 episodes in 71 patients. Terminal delirium occurred in 46 (88%) of the 52 deaths. In univariate analysis, psychoactive medications, predominantly opioids (HR, 8.85; 95% confidence interval [CI], 2.13-36.74), and dehydration (HR, 2.35; 95% CI, 1.20-4.62) were associated with reversibility. Hypoxic encephalopathy (HR, 0.39; 95% CI, 0.19-0.80) and metabolic factors (HR, 0.44; 95% CI, 0.21-0.91) were associated with nonreversibility. In mulitivariate analysis, psychoactive medications (HR, 6.65; 95% CI, 1.49-29.62), hypoxic encephalopathy (HR, 0.32; 95% CI, 0.15-0.70), and nonrespiratory infection (HR, 0.23; 95% CI, 0.08-0.64) had independent associations. Patients with delirium had poorer survival rates than controls (P<.001). Delirium is a frequent, multifactorial complication in advanced cancer. Despite its terminal presentation in most patients, delirium is reversible in approximately 50% of episodes. Delirium precipitated by opioids and other psychoactive medications and dehydration is frequently reversible with change of opioid or dose reduction, discontinuation of unnecessary psychoactive medication, or hydration, respectively.

Congruence between Patients’ and Family Caregivers’ Perceptions of Symptom Distress in Patients with Terminal Cancer

Congruence between Patients’ and Family Caregivers’ Perceptions of Symptom Distress in Patients with Terminal Cancer

1077 - Symptom distress in patients with advanced non-small cell lung cancer treated with chemotherapy

1077 - Symptom distress in patients with advanced non-small cell lung cancer treated with chemotherapy

1386 - Effects of an instruction card about diarrhea on the self-care knowledge — Behavior and symptom distress of patients receiving pelvic radiation therapy

1386 - Effects of an instruction card about diarrhea on the self-care knowledge — Behavior and symptom distress of patients receiving pelvic radiation therapy

1393 - Effects of an instruction card about fatigue on the self-care knowledge, -behavlor and symptom distress of patients receiving cephalic, thoracic and pelvic radiation therapy

1393 - Effects of an instruction card about fatigue on the self-care knowledge, -behavlor and symptom distress of patients receiving cephalic, thoracic and pelvic radiation therapy

Developing a symptom distress scale for terminal malignant disease

Symptom control is an important component of palliative care. The degree of distress caused by symptoms is individual. Instruments to measure symptom distress in patients with cancer have been developed, but have been poorly validated in the terminally ill. This study was an exploratory, descriptive, cross-sectional survey of 49 dying cancer patients, 60 professional carers (doctors and nurses) and 30 bereaved relatives. Semi-structured interviews were used to identify distressing symptoms for the dying cancer patient. The results indicated a diversity in the symptom experience and were used in the development of a physical symptom distress scale. Items were selected from a pool of symptoms generated from the three data sources, and compared with the literature of symptom distress in general cancer patients and symptom prevalence studies in terminal care. These were then compared with existing symptom distress scales. An adaptation of the physical sub-scale of the Rotterdam Symptom Checklist is proposed.

Symptom experience

To provide an overview of symptom experience, symptom occurrence, and symptom distress. Published articles relating to the symptom experience, symptom occurrence, and symptom distress of patients with cancer. Symptom experience must include both the occurrence and distress associated with the symptom. To adequately assess symptom experience, obtaining information from patient about the occurrence and distress of the symptom experience is essential. Nurses and other health care professionals can perform an essential role in the identification and management of symptom experience, thereby improving patient quality of life.

The Effect of Perceived Social Support and symptom Distress of Patients with cancer on hope

The Effect of Perceived Social Support and symptom Distress of Patients with cancer on hope